IBD Predicts Cognitive Loss — and Vice Versa – in Seniors

Published Date: 04 Mar 2026

Active IBD in older adults is linked to higher odds of cognitive decline over 1 year, and deficits in delayed recall signal an increased risk for active disease.

Read Full News

Latest News

Many Clinical Paths Are Open to NPs. Here’s Help in Picking

‘A strength of the nurse practitioner profession is its versatility,’ one expert says.

What’s That? Metabolic Disorders Driving Hearing Loss

Often it’s the drugs prescribed to treat obesity and diabetes that may be the cause of hearing issues.

Medicaid Expansion Tied to Reduced Lung Cancer Survival Gaps

After Medicaid expansion, early-stage diagnosis and 3-year survival improve among Americans with lung cancer, primarily those living in nonurban areas.

When GLP-1 Users Choose Meal Replacements, Landmines Linger

Protein bars and shakes may be options, but details matter. Other options are likely better.

Alabama Warns Healthcare Providers Against Use Of Non-FDA-approved Peptides

Alabama's medical regulator on Tuesday warned healthcare providers against prescribing or using so-called research-grade ⁠peptides, saying the substances are not approved by...

Sexual Desire in Menopause May Reflect Psychosocial Factors

Evidence suggests that sexual function may remain stable or improve after menopause, challenging assumptions of decline.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

‘A strength of the nurse practitioner profession is its versatility,’ one expert says.

Often it’s the drugs prescribed to treat obesity and diabetes that may be the cause of hearing issues.

After Medicaid expansion, early-stage diagnosis and 3-year survival improve among Americans with lung cancer, primarily those living in nonurban areas.

Protein bars and shakes may be options, but details matter. Other options are likely better.

Alabama's medical regulator on Tuesday warned healthcare providers against prescribing or using so-called research-grade ⁠peptides, saying the substances are not approved by...

Evidence suggests that sexual function may remain stable or improve after menopause, challenging assumptions of decline.

News All Time

Higher Body Fat Tied to Lower Kidney Function in Adults

Higher body and fat mass are associated with lower kidney function, particularly in women and adults older than 40 years, whereas greater fat-free mass is linked to better eGFR.

Youth Mental Health Model Shifts Care to Community Settings

A multiservice model that also supports youth with complex mental health needs shows that an inclusive approach offers a return on investment.

STI Screening and Prenatal Care Gaps in Pregnant ED Patients

Pregnant individuals in the emergency department have low rates of sexually transmitted infection screening and limited access to prenatal care, a study finds.

Brazil Advances New Vaccine Approach for P vivax Malaria

Brazilian researchers are developing vaccine candidates tailored to the country’s predominantly P vivax malaria burden, with one approach moving toward human testing.

SCD Pain Treatment Fails Despite Early Promise

Individuals hospitalized for sickle cell disease acute pain episodes were randomly assigned to receive either intravenous or saline placebo.

Rome Criteria for IBS: When Is Further Testing Needed?

Many clinicians recognize irritable bowel syndrome by its Rome criteria, but still order unnecessary tests, highlighting gaps in the application of positive diagnostic strategies.

BfR Warning: Infant Hypervitaminosis D Needs Vigilance

Vomiting, poor feeding, and failure to thrive may signal more than common infant illness. BfR urges clinicians to consider vitamin D overdose and hypercalcemia.

Could Childhood Obesity Risk Begin Before Birth?

Emerging evidence links prenatal biology and early-life exposures to later obesity risk, suggesting that prevention may need to begin before excess weight develops.

Novonesis Expects Results From Weight-loss Drug Supplement Study in 2027

Danish biosolutions maker Novonesis expects results in the second half of 2027 from research ⁠with Novo Nordisk into whether microbiome supplements could provide additional...

Celon Pharma's Generic Semaglutide Drug Matches Ozempic in Early Study, Shares Jump

Celon Pharma's experimental semaglutide product Reduzek, a generic alternative ⁠to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster weight-loss ⁠drugs in an...

Prepubertal T1D Onset Tied to Lower Risk for Complications

Children diagnosed with T1D before age 7 may face a lower risk for long-term chronic complications in the first 20 years post-diagnosis than those diagnosed later in childhood.

CKD in Diabetes: Fewer New Cases, More Burden in Denmark

Among adults with type 1 and type 2 diabetes in Denmark, the incidence of CKD declined from 2016 to 2024 even as its prevalence rose, and mortality remained substantially higher in those with CKD.

NICE Supports Weekly Insulin Jab for Type 2 Diabetes

Once-weekly insulin efsitora alfa won NICE backing for adults with type 2 diabetes after trials showed glucose control similar to that with established basal insulins, with fewer injections.

Fad or Fact: Is Gelatin Really ‘Nature’s Ozempic’?

Gelatin can promote a feeling of fullness, but it’s unlikely to result in weight loss over the long term.

Maternal Autoimmune Disease Tied to Child Mental Health Risks

Children born to mothers with systemic autoimmune rheumatic diseases have higher risks for a range of mental health conditions, particularly anxiety disorders, a study finds.

TERT Variants, Not Age, Predict Thyroid Cancer Outcomes

New findings challenge the current use of strict age cutoffs in staging papillary thyroid cancer.

Recommended News For You

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

Oleanolic acid from grapes may increase chemotherapy effectiveness

Patients value communication skills from cancer surgeons across six key areas, according to research

Year in Review: Multiple Myeloma

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

New Zealand and Australian breast cancer rates among the highest in the world, global study finds

Recommended Articles For You

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer 

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

1.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

2.

Progressive Insights in Hematology in the Digital Era

3.

Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective

4.

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources

5.

The Rise of Immunotherapy: New Advances in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

2.

Blood Clotting Disorders Explained

3.

Sickle Cell Disease Explained

4.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot